ASX Share rice
Thu 13 May 2021 - 12:09:pm (Sydney)

BOT Share Price

BOTANIX PHARMACEUTICALS LTDBOTPharmaceuticals, Biotechnology & Life Sciences

BOT Company Information


Botanix Pharmaceuticals Limited





GIC Industry:


GIC Sub Industry:



50 Angove Street North Perth WA Australia 6006


61 8 6555 2945

Full Time Employees:


MD, Pres & Exec. Chairman:

Mr. Vincent P. Ippolito

Chief Scientific Officer & Exec. Director:

Dr. Henry William Bosch

Exec. Director:

Mr. Matthew Callahan L.L.B., M.B.A., MBA LLB

Chief Medical Officer:

Dr. Clarence L. Young

Head of Commercial:

Ms. Lynda Berne

Company Sec.:

Mr. Simon Robertson C.A., B.Bus, M Appl. Fin, CA

Company Overview:

Botanix Pharmaceuticals Limited, a clinical stage synthetic cannabinoid pharmaceutical company, engages in the research and development of dermatology and antimicrobial products in Australia. It offers BTX 1503, a transdermal gel formulation for the treatment of serious acne in adults and teenagers that has completed Phase II clinical trials; BTX 1801, which is in Phase IIa clinical trials for the treatment of staphylococcus aureus and methicillin resistant staphylococcus aureus; and BTX 1702 that is in Phase II clinical trials for the treatment of papulopustular rosacea. The company was incorporated in 1984 and is based in North Perth, Australia.

BOT Share Price Information

Shares Issued:


Market Capitalisation:


Revenue (TTM):


Revenue Per Share (TTM):


Earnings per Share:


Profit Margin:


Operating Margin (TTM):


Return On Assets (TTM):


Return On Equity (TTM):


Quarterly Revenue Growth (YOY):


Gross Profit(TTM):


Diluted Earnings Per Share (TTM):


BOT CashFlow Statement

CashFlow Date:




Change To Liabilities:


Total Cashflow From Investing Activities:


Net Borrowings:


Net Income:


Total Cash From Operating Activities:




Other Cashflow From Investing Activities:


Change To Account Receivables:


Sale Purchase Of Stock:


Capital Expenditures:


BOT Income Statement

Income Date:


Income Before Tax:


Net Income:


Operating Income:


Other Operating Expenses:


Interest Expense:


Total Revenue:


BOT Balance Sheet

Balance Sheet Date:


Total Liabilities:


Total Stockholder Equity:


Total Assets:


Common Stock:


Retained Earnings:




Total Current Liabilities:


Property - Plant & Equipment:


Net Tangible Assets:


Long-Term Investments:


Total Current Assets:


Net Receivables:


Short-Term Investments:


Accounts Payable:


Short-Term Investments:


Non Current Liabilities Total:


BOT Share Price History

BOT News

08 Mar, 2021
We can readily understand why investors are attracted to unprofitable companies. For example, although made...
02 Feb, 2021
Clinical stage synthetic cannabinoid company Botanix Pharmaceuticals Limited has today published positive data from a world first human clinical study, examining the safety, tolerability and efficacy of its BTX 1801 antimicrobial product for the eradication of Staphylococcus Aureus (Staph).
08 Dec, 2020
It might seem bad, but the worst that can happen when you buy a stock (without leverage) is that its share price goes...
09 Oct, 2020
We feel now is a pretty good time to analyse Botanix Pharmaceuticals Limited's (ASX:BOT) business as it appears the...
10 Aug, 2020
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
We can readily understand why investors are attracted to unprofitable companies. For example, although...